We would like to share with you the report on HIV Criminalisation in the EU, which is a result of the two-phase study AAE  conducted in the framework of the European HIV Legal Forum.

In the first phase in 2018-2019, the data was collected from 10 countries. In the second phase, 2022 the data from the initial 10 countries was updated and collected from 10 new ones. The report includes information on the impact of legislation introduced during the COVID-19 pandemic, as well as trends, developments, and expected changes regarding the criminalisation of HIV.

Pre-exposure prophylaxis (PrEP) with oral antiretroviral medication is a highly effective and evidence-based HIV prevention method.  Despite its high clinical efficacy, efforts to expand the use of oral PrEP in EU/EEA countries have not fully realised its potential as part of combination prevention due to a variety of factors related to accessibility, affordability, and acceptability.

In this year’s report, Transgender Europe gives an overall assessment of how the strategy is delivering (or not) for trans people in the EU, as well as an update of what has been achieved toward the biggest highlights that we identified in our last report. We also include examples of how TGEU has been supporting the implementation of the strategy and our recommendations. Finally, we comment on other features of the strategy that were highlighted in our last report and present a table of main pieces of legislation and their status.